Reading time is <1 mins


World scientists also began questioning the drug Favipiravir after a year of hydroxychloroquine given to Covid-19 patients. Member of the Working Group on the pandemic of the Turkish Medical Association (TTB) said that because he used the drug Favipiravir, patients whose liver tests were impaired and had serious side effects were seen.

After hydroxychloroquine used in Covid-19 patients, Favipiravir was also the subject of discussion, although the World Health Organization advised against use and TTB and specialty associations warned for 12 months. Pandemic Working Group Member Prof. Dr. said that there is confusion in the literature about Favipiravir, which is frequently used in the world.

“We see patients whose liver tests are impaired and who have serious side effects because they use this drug in practice,” was said. So when we look at the new guide in this sense, there is a definition that should be used in patients over the age of 50 and with other diseases. We can accept this as a sign that confidence in the drug used is low,” was said.


Another problem is related to blood thinners, Prof. Dr. said, “it is very unnecessary and is used very widely in patients who do not need it. Both drugs that prevent clotting in the artery and drugs that prevent clotting in the veins are used together. As a result, serious bleeding occurs in patients, which causes them to die unexpectedly, where they stand,” he said, noting that they received these messages from many places.


“If the treatment is necessary, these treatments should not be recommended to Covid-19 patients at home. Or, when patients are discharged, if the doctor deems it appropriate, the dose and duration applied should be determined by the Turkish doctor and recommended,” he said.


Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.


Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.


Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.


Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me